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Members of the /31 or very late antigen (VLA) integrin family 
represent the predominant class of integrin extracellular ma-
trix receptors. Adhesion assays were developed for the iden-
tification of the /31 integrins involved in the adhesive inter-
actions between Langerhans cells (which mainly express 
a4/31, as/31, and a6/31) and extracellular matrix proteins. For 
this purpose, binding assays were performed on fibronectin-, 
laminin-, collagen tyre IV -, and collagen type I -coated 
plates. 59% ± 21 % 0 Langerhans cells (LC) specifically at-
tached to fibronectin. Using as inhibitory probes monoclonal 
antibodies against the /31, as, and a3 chains and the synthetic 
peptide GRGDSP resulted in a decrease of 43%,41 %, 15%, 
and 42% respectively of LC binding to fibronectin. 76% ± 
20% of LC specifically adhered to laminin. Anti-a6 mono-
clonal antibody potently inhibited this adhesion, which 
dropped to 36%, whereas the synthetic peptide GRGDSP 
was ineffective. A low number of LC adhered to type I and 
L angerhans cells (LC) are bone marrow - derived cells, localized within the microenvironment of the epider-mis. Their main function is immune in nature. They can capture and process antigens that cross the epidermal barrier. Then they migrate to the regional lymphoid 
tissues where they are potent stimulators of antigen-specific T-cell 
activation [1]. Thus, LC must attach to and then traverse basement 
membrane and connective tissue to arrive at target sites. This pro-
cess implies interactions with extracellular matrix proteins (ECM). 
LC possess cell-surface receptors for the ECM, known as /31 inte-
grins, that recognize FN, LM, and collagen [2]. In the present study, 
we have investigated potential mechanisms of LC migration by 
examining the interaction of LC with ECM. 
Isolated normal human epidermal cells were obtained by trypsin 
di gestion (0.05% trypsin, 18 h, +4°C) of surgical skin specimens. 
LC enrichment was performed through gradient sedimentation [3]. 
In order to eliminate basal keratinocytes, these LC-enriched suspen-
sions were then allowed to adhere to type I collagen - coated plates 
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ECM: extracellular matrix proteins 
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FN: fi.bronectin 
LC: Langerhans cells 
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MoAb: monoclonal antibody 
type IV collagen (13 -15%). These results indicate that as/31 
and a6/31 were the major /31 integrins involved in LC adhe-
sion to fibronectin and laminin. Ultrastructural cell morphol-
ogy of adherent cells was examined and showed that LC were 
largely spread on laminin and became tightly bound to the 
substrate on a large portion of membrane. On fibronectin 
surface, the contact between LC and substrate was smaller, 
thus cells could conserve their general round aspect. More-
over, LC binding to fibronectin and laminin induced a signi-
ficative decrease of the Birbeck granule number. 
The finding that LC attach to LM and FN in vitro suggests 
they exist similarly in vivo. By mediating a passage through 
basement membrane and migration throughout the fibronec-
tin network of the dermis, as/31 and a6/31 could contribute 
to the ability of LC to migrate into and out of the epidermis.] 
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and the non-adherent cell suspensions thus recovered were used in 
cell adhesion assays [4]. The ability ofLC to bind to LM-, FN-, and 
type I - or type IV collagen-coated surfaces was analyzed. The num-
ber of cells in non-adherent and adherent suspensions on the one 
hand, and the percentage of LC in these populations on the other 
hand [identified by staining with anti-CDla MoAb [3], followed by 
fluorescein-activated cell sorter (FACS) analysis] allowed us to cal-
culate the number of non-adherent and adherent LC. 59% ± 21 % 
of LC specifically attached to fibronectin (FN). Addition of MnCl2 (1 mM) to the assay resulted in an increase of FN LC adhesion of 
88%. Ultrastructural cell morphology revealed that a large mem-
brane portion of adherent LC was in contact with the substrate (Fig 
1) . Using as inhibitory \?robes MoAb against the /31 [5], as (Telios, 
La Jolla, CA), and a3 [6J chains and the synthetic peptide GRGDSP 
(Telios), which is able to inhibit cellular adhesion mediated by as/31 
and a3/31, resulted in a decrease of 43%,41 %, 15%, and 42% respec-
tively of LC binding to FN. Inhibitions of LC adhesion to FN 
obtained with anti-/31-chain MoAb and hexapeptide GRGDSP 
being identical suggest that LC binding to FN, which is /31 integrin 
dependent, is mediated only by an RGDS site. a4/31, which binds to 
FN by the GPEILDVPST sequence in the CSI site [7], would thus 
not be involved in LC attachment to FN. Both a3/31 and as/31 have 
been demonstrated to mediate FN adhesion by RGD site and their 
binding to an RGD peptide and to an FN fragment was shown to be 
strongly upregulated by manganese [8]. Therefore, a3/31 and a5/31 
could both be involved in LC binding to FN. However, binding to 
FN mediated by a3/31 proved to be much less pronounced than that 
mediated by aSp1. as/31, which is the specific FN receptor among 
integrins, is more largely expressed by a greater number of LC 
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Figure 1. Ultrastructural morphology of adherent cells to FN. LC were 
fixed attached on the bottom of the pl~tes coated with FN. Though they 
conserve their gener~l round and dendntlc aspect, a large portlon of mem-
brane is in contact wIth the substrate. Bg are not observed. 
Figure 3. Ultrastructural morphology of ad-
herent cells to type IV collagen. Only a few 
dendrites are in contact with the substrate. The 
general aspect of LC is preserved. Arrowheads, 
Birbeck granules. 




Figure 2. Ultrastructural morphology of adherent cells to LM. LC become 
flattened and lie on the substrate. Arrowhead, Birbeck granules. 
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(77%) than a3{31 (40%) [2] and appears as the major active FN 
receptor on LC. Furthermore, receptors such as cxv{31, recently 
shown to mediate FN adhesion [9], could also be involved in LC 
adhesion to FN. 
a6{31 is expressed by 90% of LC and is the most abundant {31 
integrin on the LC surface [2]. {34, which can also be associated with 
a6, was not found on LC. 76% ± 20% of LC were able to adhere 
specifically to LM and ultrastructural cell morphology of adherent 
cells showed that LC were largely spread on laminin and became 
tightly bound to the substrate on a large portion of membrane (Fig 
2). Anti-a6 MoAb [10] potently inhibited this adhesion, which 
dropped to 36%, whereas the synthetic peptide GRGDSP was inef-
fective. This indicates that a6{31 clearly contributes to LC adhesion 
to LM. However, the inability of the a6 MoAb to completely in-
hibit LC adhesion to LM does not exclude the potential involve-
ment of receptors such as al{31, a2{31, a3{31 (poorly expressed by 
40% ofLC), av{33 [10], and also different LM receptors such as the 
67 -kDa receptor, galactoside-binding lectins, sulfatides [11]. which 
could be present on LC. A low number of LC adhered to type I and 
IV collagen (13% ± 3% and 15% ± 6%, respectively). Electronmi-
croscopy analyses showed that LC did not spread on collagen (Fig 3) 
as they did on FN and especially on LM, suggesting that the interac-
tion between LC and collagen is not strong. 
These in vitro interactions between LC and ECM lend support to 
the concept that in vivo such interactions could permit LC to attach 
to and migrate through the basement membrane and throughout 
the FN network of the dermis before migration to the lymph nodes 
where they present antigens to T cells. In vitro tests are further 
needed in order to assess the involvement of {31 integrins in LC 
migration. Furthermore, a significant decrease in the number ofBg 
in the LC population attached to LM (8 ± 5) and to FN (3 ± 3) was 
observed with regard to the Bg number in non-adherent cells 
(15 ± 7 and 19 ± 10, respectively). This loss was very rapid because 
adhesion assays were performed for only 45 min. Are these changes 
the direct consequence of LC binding to LM and FN? Integrins are 
integral membrane proteins that are involved in the transmembrane 
linkage between the extracellular matrix and the cytoskeleton and 
any changes in the relationship between ligand and receptor can 
transmit a start signal to relay a cellular message [12]. In the case of 
LC, one message transmitted by the LC {31 integrin-ECM interac-
tions could be the loss of Bg. This might indicate that Bg are very 
specific markers of LC located in the epidermal compartment. Such 
interactions between LC ~nd matrix proteins may be a fruitful 
model to investigate the regulation of the LC behavior during their 
journey from epidermis to lymph nodes. 
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